• 2-NBDG Glucose Uptake Assay Kit: Advancing Cancer Metabolism

  2026-06-26

  The 2-NBDG Glucose Uptake Assay Kit empowers researchers to measure cellular glucose uptake rapidly and sensitively, streamlining workflows without radioactive hazards. Leveraging fluorescence-based detection, this kit enables single-cell analysis and precise interrogation of metabolic pathways—ideal for cancer, diabetes, and obesity research.

• ABT-199 (Venetoclax): BCL-2 Inhibition Beyond Hematology

  2026-06-26

  Explore how ABT-199, a potent Bcl-2 inhibitor, advances apoptosis research from hematologic malignancies to solid tumors. This article uniquely integrates high-content single-cell insights and protocol parameters to guide Venetoclax application in complex disease models.

• Trifluoperazine 2HCl: Advanced Dopamine D2 Receptor Inhibito

  2026-06-25

  Trifluoperazine 2HCl from APExBIO delivers nanomolar potency and exceptional solubility for high-sensitivity dopamine D2 receptor signaling studies, neuropharmacology assays, and macrophage modulation. This guide synthesizes protocol enhancements, troubleshooting strategies, and cross-disciplinary research applications to empower reproducible, insightful experimental outcomes.

• Berberine–Evodiamine Modulate GERD via TAS2R38/TRPV1 Pathway

  2026-06-25

  This study demonstrates that combined berberine and evodiamine treatment alleviates gastroesophageal reflux disease (GERD) through the TAS2R38/TRPV1-mediated regulation of MAPK/NF-κB signaling and macrophage polarization. The findings offer mechanistic insight into how targeting bitter taste and TRPV1 receptors can reduce esophageal inflammation, with implications for translational research on epithelial barrier restoration.

• Chenodeoxycholic Acid in CI-AKI Models: Protocols & Innovati

  2026-06-24

  Chenodeoxycholic Acid (CDCA) is redefining cholesterol metabolism and acute kidney injury research by precisely targeting FXR-KLF11 signaling. This guide translates the latest mechanistic insights and published protocols into actionable, bench-ready workflows—empowering researchers to optimize nuclear receptor signaling studies with confidence.

• JNJ-10198409: Precision Platelet-Derived Growth Factor Recep

  2026-06-23

  JNJ-10198409 empowers researchers with nanomolar precision in targeting PDGF-BB-driven signaling, enabling robust antiangiogenic and antiproliferative studies. Its versatility and potency streamline experimental workflows in cancer biology and fibrotic disorder research, backed by clear protocols and troubleshooting strategies.

• Dasatinib Monohydrate: Translational Leverage in Tumor Compl

  2026-06-23

  Explore how Dasatinib Monohydrate (BMS-354825) empowers translational researchers to navigate tumor heterogeneity, resistance mechanisms, and preclinical modeling—bridging mechanistic insight with strategic experimental guidance. This thought-leadership article integrates evidence from advanced assembloid models and highlights actionable workflow protocols, offering a visionary outlook for next-generation oncology research.

• Translating BET Bromodomain Inhibition: (+)-JQ1 in Action

  2026-06-22

  This article delivers a strategic, mechanistically rich perspective on Bromodomain Inhibitor, (+)-JQ1—a flagship BET bromodomain inhibitor from APExBIO—bridging atomic-level mechanisms, translational workflows, and clinical potential in oncology, inflammation, and reproductive biology. By integrating cutting-edge evidence, competitive context, and actionable guidance, it empowers researchers to drive next-generation discoveries with (+)-JQ1.

• Lopinavir (ABT-378): Optimizing HIV Protease Inhibition Assa

  2026-06-22

  Lopinavir (ABT-378) is transforming HIV infection research and antiviral assay workflows with unmatched potency, serum resilience, and cross-pathogen promise. This guide provides applied protocols, troubleshooting strategies, and insights from pivotal studies to maximize reproducibility and data quality in resistance and inhibition assays.

• G-15: Precision GPR30 Antagonism for Advanced Estrogen Signa

  2026-06-21

  Explore how G-15, a selective G protein-coupled estrogen receptor antagonist, enables precise dissection of estrogen signaling mechanisms. This in-depth article uniquely connects G-15’s molecular action to practical assay design and highlights new insights on GPR30’s role in neuropathic pain.

• Applied Workflows with Bromodomain Inhibitor, (+)-JQ1

  2026-06-20

  Bromodomain Inhibitor, (+)-JQ1 empowers researchers to dissect BET protein function, optimize apoptosis and ferroptosis assays, and achieve non-hormonal male contraception in preclinical models. This article delivers step-by-step protocols, troubleshooting strategies, and the latest translational insights—directly linking mechanistic breakthroughs to practical workflows.

• Dasatinib Monohydrate: Optimized Protocols in CML Research

  2026-06-19

  Dasatinib Monohydrate (BMS-354825) stands out as a multitargeted kinase inhibitor, specifically empowering chronic myeloid leukemia and imatinib-resistant research models. This guide details experimental workflows, troubleshooting strategies, and translational insights, bridging foundational kinase biology with advanced tumor modeling.

• MALAT1 Modulates PCT via miR-125b/STAT3 in Sepsis: Mechanist

  2026-06-19

  This study uncovers how the long noncoding RNA MALAT1 regulates procalcitonin (PCT) expression in sepsis through targeted modulation of the miR-125b/STAT3 axis. The findings clarify a molecular pathway underlying PCT elevation in sepsis, offering a foundation for improved diagnostic and therapeutic strategies.

• Anlotinib Hydrochloride: Advancing Translational Angiogenesi

  2026-06-18

  Unpacking the mechanistic, experimental, and strategic value of Anlotinib hydrochloride as a next-generation multi-target tyrosine kinase inhibitor, this thought-leadership article guides translational scientists in leveraging its superior anti-angiogenic properties for robust cancer research. Drawing on peer-reviewed data and cross-referencing recent content assets, we explore how APExBIO’s Anlotinib hydrochloride enables innovative assay design, competitive benchmarking, and visionary research planning.

• PINK1 Deficiency Mitigates Bleomycin-Induced Pulmonary Fibro

  2026-06-18

  This study uncovers a non-canonical role for PINK1 in pulmonary fibrosis, demonstrating that its deficiency enhances BNIP3/FUNDC1-mediated mitophagy and reduces alveolar injury in a bleomycin-induced mouse model. The findings suggest new therapeutic directions for targeting mitochondrial quality control in fibrotic lung disease.

14881 records 1/993 page Next 12345 下5页 Last page